Modern Healthcare Technology Holdings Limited (HK:0919)
:0919
Want to see HK:0919 full AI Analyst Report?
Top Page
Modern Healthcare Technology Holdings Limited
(0919)
Select Model
Select Model
Rating:53Neutral
Price Target:
HK$0.08
▲(0.00% Upside)
Action:Reiterated
Date:02/11/26
The score is primarily constrained by weak financial performance (revenue decline, negative profitability, and negative ROE). Technicals are also soft with the stock below key moving averages. Valuation is the main offset, supported by a low P/E.
Positive Factors
Improved leverage
An improved debt-to-equity ratio indicates the company has been reducing leverage or growing equity, enhancing financial flexibility. Over 2-6 months this reduces interest burden and bankruptcy risk, enabling more predictable cash allocation to operations, capex, or deleveraging.
Negative Factors
Revenue decline
Declining revenue growth reduces scale and weakens the firm's ability to cover fixed costs, compressing margins and hindering investment. Over several months this trend can signal demand deterioration or competitive pressure that impedes sustainable recovery and cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved leverage
An improved debt-to-equity ratio indicates the company has been reducing leverage or growing equity, enhancing financial flexibility. Over 2-6 months this reduces interest burden and bankruptcy risk, enabling more predictable cash allocation to operations, capex, or deleveraging.
Read all positive factors
Modern Healthcare Technology Holdings Limited (0919) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$85.93M
Dividend YieldN/A
Average Volume (3M)71.60K
Price to Earnings (P/E)4.8
Beta (1Y)-0.11
Revenue Growth-3.40%
EPS Growth515.63%
CountryHK
Employees850
SectorConsumer Cyclical
Sector Strength84
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)0.02
Shares Outstanding904,483,950
10 Day Avg. Volume65,200
30 Day Avg. Volume71,600
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)0.36
Price to Sales (P/S)0.15
P/FCF Ratio0.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model
Company Description
Modern Healthcare Technology Holdings Limited operates as an investment holding company, offering a wide array of beauty and wellness services across Hong Kong, mainland China, Singapore, and Australia. The company's activities are structured into...
How the Company Makes Money
The company generates revenue through multiple streams, primarily by selling its healthcare technology products and services to hospitals, clinics, and other healthcare facilities. This includes software licensing fees, subscription services for o...
Modern Healthcare Technology Holdings Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
60
Neutral
| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 453.41M | 453.27M | 454.71M | 406.33M | 355.59M | 431.45M |
| Gross Profit | 130.45M | 165.26M | 166.96M | 394.72M | 341.52M | 417.67M |
| EBITDA | 91.50M | 77.11M | 95.68M | 70.72M | 26.39M | 240.65M |
| Net Income | 17.78M | -5.07M | -9.57M | -20.61M | -68.81M | 125.72M |
Balance Sheet | ||||||
| Total Assets | 561.80M | 564.46M | 611.04M | 561.35M | 570.96M | 669.04M |
| Cash, Cash Equivalents and Short-Term Investments | 301.73M | 236.67M | 193.66M | 177.53M | 127.53M | 234.34M |
| Total Debt | 62.90M | 68.65M | 106.57M | 40.11M | 65.01M | 115.07M |
| Total Liabilities | 362.05M | 373.26M | 416.65M | 357.47M | 347.75M | 376.15M |
| Stockholders Equity | 193.99M | 185.85M | 189.33M | 199.77M | 219.58M | 289.37M |
Cash Flow | ||||||
| Free Cash Flow | 153.70M | 134.94M | 64.08M | 125.52M | -29.55M | 121.64M |
| Operating Cash Flow | 162.01M | 151.09M | 78.66M | 139.82M | 51.31M | 123.88M |
| Investing Cash Flow | -28.23M | -50.50M | 8.16M | -13.17M | -79.96M | -2.85M |
| Financing Cash Flow | -64.34M | -66.24M | -70.60M | -77.31M | -78.46M | -77.89M |
Modern Healthcare Technology Holdings Limited Technical Analysis
Neutral
0.08
Price Trends
0.09
Positive
0.09
Positive
0.08
Positive
Market Momentum
<0.01
Positive
49.37
Neutral
48.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0919, the sentiment is Neutral. The current price of 0.08 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.09, and below the 200-day MA of 0.08, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 49.37 is Neutral, neither overbought nor oversold. The STOCH value of 48.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0919.
Modern Healthcare Technology Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$1.38B | 8.59 | 39.78% | 9.92% | -23.31% | -44.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$6.03B | -26.12 | -3.80% | 19.70% | -28.00% | -129.57% | |
53 Neutral | HK$85.93M | 4.85 | 10.10% | ― | -3.40% | 515.63% | |
53 Neutral | HK$101.60M | -21.90 | -25.18% | 7.50% | -32.83% | -1040.00% | |
49 Neutral | HK$1.77B | 57.37 | 5.58% | ― | 3.16% | -53.52% | |
43 Neutral | HK$18.62M | -2.46 | -3.96% | ― | -14.18% | 23.83% |
* Consumer Cyclical Sector Average
HK:0919
Modern Healthcare Technology Holdings Limited
0.10
0.02
21.79%
HK:1448
Fu Shou Yuan International Group
2.64
-0.69
-20.61%
HK:1830
Perfect Medical Health Management Limited
1.10
-0.57
-34.13%
HK:8296
Sino-Life Group Limited
0.20
-0.10
-34.33%
HK:8483
Max Sight Group Holdings Limited
0.13
-0.07
-36.50%
HK:2521
Shenghui Cleanness Group Holdings Limited
0.91
0.62
213.79%
Modern Healthcare Technology Holdings Limited Corporate Events
Modern Healthcare Technology Wins Independent Backing for 2026 Master Lease Deal
Mar 30, 2026
Independent shareholders of Modern Healthcare Technology Holdings Limited have approved the company’s 2026 Master Lease Agreement, along with the related transaction arrangements and annual caps, at an extraordinary general meeting held on M...
Modern Healthcare Tech Calls EGM to Approve 2026 Master Lease Arrangements
Mar 13, 2026
Modern Healthcare Technology Holdings Limited has called an extraordinary general meeting in Hong Kong on 30 March 2026 to seek shareholder approval for transactions under its 2026 Master Lease Agreement, as varied by a supplemental agreement, and...
Modern Healthcare Sets March EGM and Book Closure for 2026 Master Lease Deal
Mar 10, 2026
Modern Healthcare Technology Holdings Limited has scheduled an extraordinary general meeting for 11:30 a.m. on 30 March 2026 in Hong Kong, where shareholders will vote on matters related to a major and continuing connected transaction under the 20...
Modern Healthcare Tightens 2026 Master Lease Terms and Revises Annual Caps
Feb 27, 2026
Modern Healthcare Technology Holdings has signed a supplemental agreement to its 2026 Master Lease Agreement, capping the term of the master lease and all underlying leases at dates not extending beyond 31 March 2028. Following this change, the co...
Modern Healthcare Technology Sets 2026 Connected Master Lease, Seeks Independent Shareholder Approval
Feb 13, 2026
Modern Healthcare Technology Holdings Limited has entered into a new 2026 Master Lease Agreement with Asia Power to ensure the continuation of leasing existing premises after the expiry of the current 2023 master lease and related individual lease...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.